Use of pimobendan for the reduction of heart size and/or the delay of onset of clinical symptoms in patients with asymptomatic heart failure due to mitral valve disease

• 收藏
• 分享

专利权人:

Boehringer Ingelheim Vetmedica GmbH

发明人:

Schummer, Christoph Matthias,Joens, Olaf

申请号：

AU2017245601

公开号：

AU2017245601A1

申请日:

2017.04.04

申请国别(地区):

AU

年份:

2018

代理人:

摘要：

The invention relates to pimobendan for use in a method of reducing the heart size and/or delaying the onset of clinical symptoms in a patient suffering from asymptomatic (occult, preclinical) heart failure, preferably congestive heart failure, due to mitral valve disease (MVD), and/or delaying the onset of heart failure, preferably congestive heart failure, in a patient suffering from asymptomatic (occult, preclinical) heart failure, preferably congestive heart failure, due to mitral valve disease (MVD), wherein the patient is preferably a mammal, more preferably a human, a dog, a cat or a horse, and most preferably a dog.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/